Salmex® is an inhaler with two active substances – fluticasone propionate and salmetrol – with three forms of presentation:                                 

 – Dosage 50ug + 100ug

– Dosage 50ug + 250ug

 – Dosage 50ug + 500ug

 

       Profile:

                                           – Salmeterol – Long-acting bronchodilator used to treat and prevent bronchoconstriction in patients with reversible obstructive airway disease.

                     – Fluticasone – Inhaled corticosteroid used in bronchial asthma for the control of airway inflammation.

       Indications:

       – Maintenance treatment of reversible obstructive respiratory disease in adults and children (asthma);

       – Maintenance treatment of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.